Efficacy and Safety of Once-Weekly Semaglutide for the Treatment of Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Główni autorzy: Fang-Hong Shi (Autor), Hao Li (Autor), Min Cui (Autor), Zai-Li Zhang (Autor), Zhi-Chun Gu (Autor), Xiao-Yan Liu (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2018-06-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background: Semaglutide, a newly once-weekly glucagon like peptide-1 (GLP-1) receptor agonist, has showed a favorable effect on glycaemic control and weight reduction in type 2 diabetes mellitus (T2DM). This meta-analysis was conducted to evaluate the clinical efficacy and safety of semaglutide in T...